
By Mariam Sunny
(Reuters) -Global measles cases fell 71% to 11 million from the year 2000 to 2024, driven by improved vaccination coverage, the World Health Organization said in a report on Friday.
Vaccination has prevented nearly 59 million deaths globally during this period, according to the report.
Deaths dropped even more sharply by 88% to 95,000 in 2024, among the lowest annual tolls since 2000.
However, estimated cases in 2024 rose 8%, while deaths dropped 11%, compared with 2019 pre-pandemic levels, reflecting a shift in disease burden from low-income to middle-income countries, which have lower fatality ratios, the report said.
Measles is often the first disease to see a resurgence when vaccination coverage drops, the agency said, adding that growing measles outbreaks expose weaknesses in immunization programmes and health systems.
Due to its high transmissibility, "even small drops in vaccine coverage can trigger outbreaks, like a fire alarm going off when smoke is detected," said Kate O'Brien, director of the Department of Immunization at WHO.
(Reporting by Mariam Sunny in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Surveys of Music Collections by Film Stars - 2
The Leonid meteor shower is peaking early this week. Here’s what to know - 3
Figure out How to Modify Your Pre-assembled Home for Greatest Solace and Stylish Allure - 4
Strengthening through Wellness: Individual Preparation Achievement - 5
Which camera do you believe is great for first-time clients? !
FDA updates risk classification for voluntary shredded cheese recall
IDF strikes Hamas terror base in Lebanon, Health Ministry says 11 killed
Horses really can smell our fear, new study finds
Investigate the Excellence of Professional flowerbeds: A Virtual Local escort
Private sector revives the climate disaster database Trump tried to squash
Reports: Germany plans expansion of foreign intelligence powers
Step in Style: A Survey of \Solace and Execution on the Track\ Running Shoes
Nearly 16,000 New York City nurses prepare to strike as contract talks stall
US FDA investigates Takeda's blood disorder drug after pediatric death













